Disproportionate impact of COVID-19 on BAME populations not explained by cardiometabolic factors, vitamin D or deprivation, researchers findSubscription
Variations in cardiometabolic factors, vitamin D levels and socioeconomic or behavioural factors do not adequately explain why COVID-19 disproportionately affects black, Asian and minority ethnic populations.
People with inflammatory bowel disease have a significantly higher risk of developing dementia later in life, a study in Gut has suggested.
Biological therapies secukinumab and adalimumab are similarly effective at improving the musculoskeletal symptoms of psoriatic arthritis, a head-to-head trial suggests.
Medication overuse headache is best treated with a combination of analgesic withdrawal and pharmaceutical prophylaxis, the authors of a study in JAMA Neurology have said.
Sodium-glucose co-transporter 2 inhibitors are associated with a lower incidence of serious renal events in people with diabetes, a study in the BMJ has suggested.
There is no significant difference in efficacy between five-day and ten-day courses of the antiviral remdesivir for patients with severe COVID-19 not requiring ventilation, research published in The New England Journal of Medicine has shown.
The use of corticosteroids in coronavirus infections is associated with increased risk of death and side effects, such as bacterial infections and hypokalaemia, researchers have said.
Among people with hypertension, the severity of COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, data from Wuhan, China, suggest.
Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.